Feed TMDX
TM

TransMedics

TMDX · NASDAQ

$82.18 -3.73% (-$3.18)
1M -8.32%
Market Cap $3.05B
P/E Ratio 20.11x
Div. Yield -
ROE 32.97%

Bulios Fair Price

$96.76

17.7% upside

Trenutna cena

$82.18

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica TMDX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
35 /100
Fair
EV/EBITDA 28.72x
P/S 4.56x
P/B 5.89x
Growth
100 /100
Growing
Book val. growth 36.17%
Rev. growth 86.42%
FCF growth N/A
Profitability
78 /100
Strong
Net margin 22.69%
Op. margin 12.21%
FCF margin 11.82%
Quality
76 /100
Excellent
ROE 32.97%
ROA 10.36%
Asset turnover 0.46x
Debt
47 /100
Moderate
Current ratio 6.62x
Int. coverage 4.42x
Net debt/EBITDA 3.29x
Stability
6 /100
Unstable
Rev. volatility 61.32%
EPS volatility 172.83%
Profitable years 2

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o TMDX
Online

O podjetju

TransMedics Group, Inc. (TMDX) is an American company specializing in the development and manufacturing of innovative medical devices for organ transplantation. With the aim of improving the preservation and transportation of organs intended for transplantation, TransMedics has developed the Organ Care System (OCS) technology. This technology allows organs to be maintained in optimal condition during transportation, potentially increasing the success of transplant procedures. The company is known for its commitment to saving lives and innovations in the field of organ transplantation. TransMedics Group, Inc. (TMDX) shares could be suitable for investors looking to invest in a company actively supporting medical research and life-saving through organ transplantation.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Waleed H. Hassanein

Employees

898

Headquarters

Andover

Prihajajoči dogodki

04 NOV.

Earnings

Upcoming earnings report

53d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.